As of the 7th, there have been a total of 19 'Adverse Reaction Reports' in the Gyeongbuk region
...1 death, 1 shock (anaphylaxis), 15 mild cases, 2 hospitalized

The photo shows the COVID-19 vaccination site for elderly care facilities in Eunpyeong-gu, Seoul, held on the 2nd of last month. [Image source=Yonhap News]

The photo shows the COVID-19 vaccination site for elderly care facilities in Eunpyeong-gu, Seoul, held on the 2nd of last month. [Image source=Yonhap News]

View original image

[Asia Economy Yeongnam Reporting Headquarters Reporter Park Dong-wook] A woman in her 50s who received the AstraZeneca (AZ) vaccine in Pohang, Gyeongbuk, has died. This is the first death reported after receiving the AZ vaccine in the Gyeongbuk area.


According to Gyeongbuk Province on the 7th, at around 4:10 a.m. the previous day, a woman in her 50s, Ms. A, who had received the COVID-19 vaccine a few days earlier, died in her hospital room at a nursing hospital in Pohang where she was admitted.


The woman, who had underlying conditions including cerebral hemorrhage and wounds, received the AZ vaccine at the nursing hospital where she was admitted at around 10 a.m. on the 2nd, four days before her death.


She showed no particular symptoms from the 2nd to the 5th, but at around 3:40 a.m. on the 6th, a hospital staff member on duty witnessed abnormal symptoms during a room patrol and provided emergency treatment; however, she was pronounced dead 30 minutes later.


Gyeongbuk Province has requested the Disease Control Agency's vaccination damage investigation team to review the death case and is currently discussing an autopsy.


A Gyeongbuk Province infectious disease management official stated, "Since 90 hours have passed until the appearance of adverse reactions, the temporal proximity is low," and added, "It is unclear whether the cause of death is related to the vaccine."



Meanwhile, as of 4 p.m. on the same day, the cumulative number of vaccine recipients in Gyeongbuk is 18,688. Reports of adverse reactions after vaccination include 15 mild cases, 1 death, 1 anaphylaxis (hypersensitivity reaction), and 2 hospitalized cases, totaling 19 cases.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing